Surveying the Therapeutic Potentials of Isoliquiritigenin (ISL): A Comprehensive Review

ABSTRACT Isoliquiritigenin (ISL), a major chalcone‐type flavonoid produced predominantly from liquorice roots ( Glycyrrhiza species), has exceptional therapeutic potential across a wide range of pharmacological activities. ISL has numerous benefits including antioxidant, anti‐inflammatory, antidiabetic, cardioprotective, hepatoprotective, neuroprotective, and anticancer activities. This review gathers the pharmacological effects of ISL remarking into its mechanism of actions such as how it modulates oxidative stress, inflammatory pathways, glucose metabolism, and cancer growth, demonstrating its pharmacological versatility. The review emphasizes new advances in the field, allowing for more rational development and clinical use of ISL in medicine. However, further research is required to confirm the target‐organ toxicity or side‐effect investigations.